Recent calculations by Viridian Capital Advisors have shed light on the significant impact that eliminating Section 280e could have on the cannabis industry. This impact could potentially outweigh the effects of the SAFE Act and a TSX uplisting. Section 280e, a provision in the Internal Revenue Code, restricts businesses from deducting ordinary expenses associated with the “trafficking” of Schedule I or II substances, as defined by the Controlled Substances Act.
Members of Outlawz have said for years that they mixed some of Tupac Shakur’s ashes…
State and local police made at least 218,152 marijuana-related arrests in 2025, including 200,960 for…
Three days in Philadelphia, September 25 to 27, with a free record-clearing clinic and a…
Four decades after its Amsterdam beginnings, Barney’s Farm is marking the milestone with new markets,…
Gallup’s new numbers hold a small, awkward pattern: the Americans most convinced cannabis is bad…
The FDA is seeking outside data and analytics services to better understand how people use…